
STVN · NYSE
Stevanato Group S.p.A.
$12.53 -1.56 (-11.07%)
Company overview
Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for the pharmaceutical and healthcare industries. Its principal products include containment solutions, drug delivery systems, medical devices, diagnostics, analytical services, visual inspection machines, assembly and packaging machines, and glass forming machines. The company was founded in 1949 and is headquartered in Piombino Dese, Italy. Stevanato Group S.p.A. operates as a subsidiary of Stevanato Holding S.R.L.
- Sector
- Healthcare
- Industry
- Medical - Instruments & Supplies
- Exchange
- NYSE
- Market cap
- $3.4B
- Employees
- 5,521
- Headquarters
- Piombino Dese, PD
- Website
- stevanatogroup.com
- CEO
- Franco Stevanato
- Listed
- July 16, 2021
- P/E
- 24.53
- Dividend yield
- 0.36%
Company financials
- Revenue
- $1.2B
- Gross profit
- $348M
- Operating income
- $199M
- EBITDA
- $290M
- Net income
- $141M
- EPS
- $0.51
- Total assets
- $2.6B
- Total debt
- $449M
- Gross margin
- 29.01%
- Net margin
- 11.75%
- Earnings yield
- 4.08%
No product segmentation.
Showing FY 2025
News